Ralf Koberstein
We have observed 28 EP applications Ralf Koberstein has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 25, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:
7-(HETEROARYL-AMINO)-6,7,8,9-TETRAHYDROPYRIDO[1,2-A]INDOL ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
- IPC classification:
- A61K 31/437, A61P 37/08, C07D 471/04
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Status:
- █ PATENT GRANTED
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- IPC classification:
- A61K 31/4355, A61K 31/436, A61P 29/00, C07D 491/048, C07D 491/052
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Status:
- █ NO OPPOSITION FILED WITHIN TIMELIMIT
HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
- IPC classification:
- A61K 31/47, C07D 209/44, C07D 217/06, C07D 223/06, C07D 223/16, C07D 401/06, C07D 401/12, C07D 405/06, C07D 413/06, C07D 417/06
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- IPC classification:
- A61K 31/4355, A61P 29/00, C07D 491/048
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Status:
- █ NO OPPOSITION FILED WITHIN TIMELIMIT
4-(BENZOIMIDAZOL-2-YL)-THIAZOLE COMPOUNDS AND RELATED AZA DERIVATIVES
- IPC classification:
- A61K 31/427, C07D 417/14, C07D 471/04, C07D 487/04, C07D 519/00
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
1-(P-TOLYL)CYCLOPROPYL SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS
- IPC classification:
- A61K 31/40, A61P 3/00, C07D 207/08, C07D 207/10
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Status:
- █ PATENT GRANTED
FLUORINATED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS
- IPC classification:
- A61K 31/40, A61K 31/44, A61P 9/00, A61P 29/00, A61P 31/12, C07D 207/34, C07D 211/58
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Status:
- █ PATENT GRANTED
1-PHENYL-SUBSTITUTED HETEROCYCLYL DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
- IPC classification:
- A61K 31/4353, A61P 11/00, A61P 17/00, A61P 37/00, C07D 513/04
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Status:
- █ EXAMINATION IN PROGRESS
INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- IPC classification:
- A61K 31/405, A61K 31/506, A61P 11/00, A61P 19/00, A61P 25/28, C07D 209/08, C07D 401/12, C07D 401/14, C07D 403/12, C07D 403/14, C07D 405/14, C07D 413/12, C07D 413/14, C07D 417/12, C07D 498/08
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- IPC classification:
- A61K 31/404, A61P 29/00, C07D 209/08, C07D 209/24
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
- IPC classification:
- A61K 31/428, A61K 31/429, A61P 29/00, C07D 277/60, C07D 513/04
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS& xA;
- IPC classification:
- A61K 31/428, A61K 31/429, A61P 25/00, A61P 29/00, C07D 277/60
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
PYRIDIN-4-YL DERIVATIVES
- IPC classification:
- A61K 31/4433, A61P 37/00, C07D 413/04
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Multiple attorneys, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ The patent has been granted
NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS
- IPC classification:
- A61K 31/435, A61K 31/445, C07D 211/58, C07D 213/75, C07D 401/12, C07D 401/14, C07D 403/12, C07D 413/14, C07D 417/14, C07D 471/04
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Multiple attorneys, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ The patent has been granted
DIFLUOROETHYL-OXAZOLE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS
- IPC classification:
- A61K 31/422, C07D 413/12
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
PIPERAZINE SUBSTITUTED BRIDGED SPIRO[2.4]HEPTANE DERIVATIVES AS ALX RECEPTOR AGONISTS
- IPC classification:
- A61K 31/495, C07D 295/14
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ The patent has been granted
BENZIMIDAZOLYL-METHYL UREA DERIVATIVES AS ALX RECEPTOR AGONISTS
- IPC classification:
- A61K 31/4184, A61P 29/00, C07D 235/14, C07D 401/12, C07D 403/12, C07D 405/12, C07D 413/12, C07D 417/12, C07D 453/02, C07D 471/04, C07D 473/00
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ PATENT GRANTED
ANTIBACTERIAL 2H-INDAZOLE DERIVATIVES
- IPC classification:
- A61K 31/416, C07D 231/56, C07D 401/06, C07D 403/06, C07D 413/10
- Agent:
- Multiple attorneys, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ The patent has been granted
ANTIBACTERIAL 1H-INDAZOLE AND 1H-INDOLE DERIVATIVES
- IPC classification:
- A61K 31/404, A61K 31/416, A61P 31/04, C07D 209/08, C07D 231/56, C07D 403/06, C07D 409/06
- Agent:
- Multiple attorneys, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ The patent has been granted
1,2-DIHYDRO-3H-PYRROLO[1,2-C]IMIDAZOL-3-ONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS
- IPC classification:
- A61K 31/4188, A61K 31/496, A61K 31/5377, C07D 487/04
- Agent:
- Multiple attorneys, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ EXAMINATION REQUESTED
AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
- IPC classification:
- A61K 31/437, A61P 37/00, C07D 471/04
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ EXAMINATION REQUESTED
AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
- IPC classification:
- A61K 31/437, A61P 37/00, C07D 471/04
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ EXAMINATION REQUESTED
8-(PIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE DERIVATIVES
- IPC classification:
- A61K 31/4725, A61P 25/28, A61P 35/00, A61P 37/00, C07D 401/14, C07D 413/14, C07D 417/14, C07D 471/04
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ EXAMINATION REQUESTED
ANTIBACTERIAL QUINAZOLINE-4(3H)-ONE DERIVATIVES
- IPC classification:
- A61K 31/517, A61P 31/04, C07D 239/90
- Agent:
- Multiple attorneys, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ EXAMINATION REQUESTED
PYRAZOLE COMPOUNDS AND THEIR USE AS T-TYPE CALCIUM CHANNEL BLOCKERS
- IPC classification:
- A61K 31/415, A61K 31/4155, A61K 31/4439, A61P 3/10, A61P 9/00, A61P 15/00, A61P 25/00, A61P 35/00, C07D 231/40, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/12, C07D 405/12, C07D 405/14, C07D 413/12, C07D 471/04
- Applicant:
- Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ EXAMINATION REQUESTED
TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS
- IPC classification:
- A61K 31/4192, A61P 9/00, A61P 35/00, C07D 249/04, C07D 401/12, C07D 403/12, C07D 405/12
- Agent:
- Ralf Koberstein, Actelion Pharmaceuticals Ltd.
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ Request for examination was made
HYDROXYALKYL-PIPERAZINE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS
- IPC classification:
- A61K 31/427, A61P 37/00, C07D 417/14
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ Request for examination was made
(R)-2-METHYL-PIPERAZINE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS
- IPC classification:
- A61K 31/427, A61P 29/00, C07D 417/14
- Agent:
- Ralf Koberstein, Idorsia Pharmaceuticals Ltd
- Status:
- █ Request for examination was made